GlassScriptPhysician profile
Cindy A Parker
NPI 1427098771
$578.89
in general payments reported to CMS, 2019-2025
14 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.95 · 2021: $53.17 · 2022: $202 · 2023: $97.66 · 2024: $75.12 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $85.65 | 2022-2025 | Collagenase Santyl |
| Kci USA, INC. | $84.98 | 2022-2023 | 3m Coban, Activ.A.C., Activ.A.C. Ion Progress |
| Next Science LLC | $83.36 | 2022 | |
| Cashflow Solutions, LLC | $65.48 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kerecis Limited | $49.18 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Hydrofera LLC | $42.97 | 2021-2025 | Hydrofera Blue |
| Convatec INC. | $33.06 | 2021-2025 | |
| Ambu INC. | $29.07 | 2021 | |
| Molnlycke Health Care US, LLC | $22.07 | 2023 | Mextra Superabsorbant, Mepilex Border Post-Op Ag, Mepilex Border Sacrum |
| Reprise Biomedical, INC. | $18.25 | 2025 | Mirotract |
| Solventum Corporation | $17.89 | 2024 | Activ.A.C. |
| Genentech USA, INC. | $15.95 | 2019 | |
| Abiomed | $15.67 | 2024 | Impella |
| Medela LLC | $15.31 | 2024 | Invia Motion Endure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.